Back
MOTS-C 10mg — research compound

MOTS-C 10mg

Cellular

MOTS-c is a mitochondrial-derived peptide studied for its role in cellular energy metabolism and exercise-related signaling. Research is still largely preclinical, with interest driven by its proposed link to metabolic and longevity pathways.

Not FDA-approved; sold for research use only.

🌍Worldwide
ZenterexTop pick

Worldwide

COA / lab reports
£28.49
Shop with discount →
🇬🇧UK
24 Hour Peptides

United Kingdom

£29.95
Shop with discount →
🇺🇸USA
NextGenPeps

United States

COA / lab reports
$52.00
Shop with discount →
🇬🇧UK
Evora

United Kingdom

COA not listed — ask supplier

£95.00
Shop with discount →

The human trial is for an analog, not MOTS-c itself

The only human clinical data in this space is for CB4211, described as "a novel analog of MOTS-c" developed by CohBar — not MOTS-c itself. Same related-but-different-molecule pattern found repeatedly across this research project.

Benefits

MOTS-c is a 16-amino-acid mitochondrial-derived peptide, encoded within the mitochondrial genome itself (the 12S rRNA region) rather than nuclear DNA. It's produced in skeletal muscle in response to exercise (in a reactive-oxygen-species-dependent manner) and is reported to act mainly through the folate-AICAR-AMPK pathway, affecting glucose metabolism, insulin resistance, and exercise adaptation. This mechanistic picture comes from animal/cell studies, not human trials of MOTS-c itself.

CB4211 (MOTS-c analog), Phase 1a/1b (healthy volunteers + NAFLD patients, 28 days, 25mg subcutaneous daily, n=11 treated vs. 9 placebo): met its primary safety outcome; liver enzymes ALT and AST were reduced 25% and 17% respectively vs. placebo in the NAFLD subgroup. Development of CB4211 was subsequently discontinued, and as of this research pass there are no active Phase 2/3 trials for MOTS-c or any MOTS-c analog.

Dosage

No dose for MOTS-c itself has been clinically established — the only human dosing data (25mg/day subcutaneous) is for the CB4211 analog, not the native peptide sold as "MOTS-c."

Side Effects

CB4211 was reported safe and well-tolerated in its Phase 1 trial. No safety data exists for MOTS-c itself in humans.

Frequently asked questions

What is MOTS-c used for in research?+

Studies focus on mitochondrial function, metabolic regulation, and exercise-adaptation signaling.

Is MOTS-c FDA-approved?+

No, it is not an approved drug and is sold for research use only.

Is MOTS-c naturally occurring?+

Yes, it is encoded within mitochondrial DNA and occurs naturally in the body; the research compound is a synthesized version of that sequence.

What actually is MOTS-c — is it a normal peptide?+

Not in the usual sense — it's encoded by your mitochondrial DNA rather than your regular genome, discovered only in 2015. It's a signal your mitochondria produce themselves under stress or exercise, and production naturally declines with age.

Does exercise actually trigger it naturally?+

Yes — exercise induces your body to produce MOTS-c on its own, in muscle tissue and circulating in blood, confirmed in humans specifically, not just animal models.

Looking for something specific, or placing a wholesale order? Send us a DM or email.